Soy intake linked to lower recurrence of breast cancer in some cancers

Share this content:
Patients with hormone-sensitive cancers may lower their risk of breast cancer recurrence by increasing their soy intake, according to a study published in the Canadian Medical Association Journal (2010 Oct 18. [Epub ahead of print]).

To investigate the effects of soy isoflavones on breast cancer patients receiving adjuvant endocrine therapy, researchers at the Cancer Hospital of Harbin Medical University in Harbin, China conducted a study involving 524 women who had surgery for breast cancer and were followed afterwards for between 5 to 6 years.

“Compared with postmenopausal patients in the lowest quartile of soy isoflavone intake, those in the highest quartile had a significantly lower risk of recurrence,” wrote the study's authors. “The recurrence rate of estrogen- and progesterone- positive breast cancer was 12.9% lower among patients in the highest quartile of soy isoflavone intake than among those in the lowest quartile, and was 18.7% lower for patients receiving anastrozole therapy in the highest quartile.”

However, researchers reported that there was no effect on overall survival in postmenopausal women and no association between soy intake and survival in premenopausal women.

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs